These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 23794426)
1. [Therapy for systemic metabolic disorders based on the detection of basic corneal landmarks in childhood]. Lisch W; Pitz S; Geerling G Klin Monbl Augenheilkd; 2013 Jun; 230(6):575-81. PubMed ID: 23794426 [TBL] [Abstract][Full Text] [Related]
2. [Corneal dystrophy (CD)-induced pain and visual impairment in childhood]. Lisch W Klin Monbl Augenheilkd; 2013 Jun; 230(6):582-6. PubMed ID: 23794427 [TBL] [Abstract][Full Text] [Related]
3. [The onset of psychiatric disorders and Wilson's disease]. Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784 [TBL] [Abstract][Full Text] [Related]
4. Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. Gahl WA; Kuehl EM; Iwata F; Lindblad A; Kaiser-Kupfer MI Mol Genet Metab; 2000; 71(1-2):100-20. PubMed ID: 11001803 [TBL] [Abstract][Full Text] [Related]
5. [Corneal ring opacity (Ascher ring)--a case report]. Rohrbach JM; Kleiser N; Kaufmann-Fechner J; Lisch W Klin Monbl Augenheilkd; 2001 Apr; 218(4):276-8. PubMed ID: 11392275 [TBL] [Abstract][Full Text] [Related]
6. Variability in the ocular phenotype in mucopolysaccharidosis. Sornalingam K; Javed A; Aslam T; Sergouniotis P; Jones S; Ghosh A; Ashworth J Br J Ophthalmol; 2019 Apr; 103(4):504-510. PubMed ID: 30120129 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis. Ferrari S; Ponzin D; Ashworth JL; Fahnehjelm KT; Summers CG; Harmatz PR; Scarpa M Br J Ophthalmol; 2011 May; 95(5):613-9. PubMed ID: 20852315 [TBL] [Abstract][Full Text] [Related]
9. Corneal hysteresis in mucopolysaccharidosis I and VI. Fahnehjelm KT; Chen E; Winiarski J Acta Ophthalmol; 2012 Aug; 90(5):445-8. PubMed ID: 21232085 [TBL] [Abstract][Full Text] [Related]
10. [A case of Richner-Hanhart syndrome (tyrosinosis with ocular, cutaneous and mental manifestations]. Goddé-Jolly D; Larregue M; Roussat B; Van Effenterre G J Fr Ophtalmol; 1979 Jan; 2(1):23-8. PubMed ID: 34642 [TBL] [Abstract][Full Text] [Related]
15. Clinical picture and problems of keratoplasty in Richner-Hanhart syndrome (tyrosinemia type II). Sayar RB; von Domarus D; Schäfer HJ; Beckenkamp G Ophthalmologica; 1988; 197(1):1-6. PubMed ID: 3054681 [TBL] [Abstract][Full Text] [Related]
16. Current strategies in the management of lysosomal storage diseases. Heese BA Semin Pediatr Neurol; 2008 Sep; 15(3):119-26. PubMed ID: 18708002 [TBL] [Abstract][Full Text] [Related]
17. [Ocular findings in Fabry's disease]. Kuzman T; Juri J; Mrsić M; Jeren-Strujić B; Mandić Z; Sikić J Acta Med Croatica; 2006; 60(2):163-6. PubMed ID: 16848212 [TBL] [Abstract][Full Text] [Related]
19. Objective Quantification of Changes in Corneal Clouding Over Time in Patients With Mucopolysaccharidosis. Javed A; Aslam T; Jones SA; Ashworth J Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):954-958. PubMed ID: 28170539 [TBL] [Abstract][Full Text] [Related]
20. Corneal endothelium in mucopolysaccharide storage disorders. Morphologic studies in animal models. Mollard RJ; Telegan P; Haskins M; Aguirre G Cornea; 1996 Jan; 15(1):25-34. PubMed ID: 8907377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]